(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-bromoacrylamide, 98%, 250mg

4-Benzylmorpholin-2-one, 95.0%, 1g

8-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one, 95.0%, 25g

4-Chloro-2-fluoronicotinaldehyde, 95.0%, 25g

5-Nitro-2,3,4-trifluorobenzotrifluoride, 5g

4-(4-ethylphenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

p-Toluenesulfonic Anhydride>95.0%(T)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-cyanophenyl)propanoic acid, 95.0%, 10g

2-(ISOBUTYLAMINO)ACETIC ACID, 95.0%, 250mg

3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 100g

2-Amino-5-formyl-3-methylbenzoic acid, 95.0%, 1g

1-(5-nitro-2-thienyl)ethanone, 95.0%, 5g

(R)-(-)-alpha-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-4-hydroxybenzeneacetic Acid>98.0%(HPLC)(T)1g